Avenue Therapeutics (ATXI) stock forecast for 2022 – 2027

Are you interested in Avenue Therapeutics, Inc. stocks prediction? If yes, then on this page you will find useful information about the dynamics of the ATXI stock price in 2022-2027. Is ATXI a good long term stock? When should I take profit in Avenue Therapeutics stock? Buy or sell stock? Will ATXI stock price go up? What are analysts’ forecasts for ATXI stock?
Forecst.com predicts future values using technical analysis of a large number of analytical parameters. ATXI stock returns are also predicted based on historical data.

According to our research, ATXI stock is a bad long-term investment. ATXI share price has been in a bear cycle for the past year. Avenue Therapeutics, Inc. stock trend is negative.

Avenue Therapeutics company info

Industry Biotechnology
Address 1140 Avenue of the America, New York, NY, 10036, United States
Website https://www.avenuetx.com

Forecasting

52 Week High: 0.92862 USD
52 Week Low: 0.00000102 USD
1 Year Forecast: 0.00000102 USD
5 Year Forecast: 0 USD

Agilent Technologies info

Market Cap: 13.86M
52 Week Change: -5.474%
52 Week High: 7.69 USD
52 Week Low: 0.6011 USD
Beta: 2.14986
50 Day Moving Average: 0.873
90 Day Moving Average: 1.084
200 Day Moving Average: 1.4
Resistance Level: 0.74547
Pivot Point: 0.71736
Support Level: 0.722466
Enterprise Value: 16,133,229
Forward P/E: -3.74
Forward EPS: -0.19
Profit Margin: 0.00%
Shares Outstanding: 20,902,600
EBITDA: 0
Held Percent Institutions: 5.74%
PEG Ratio (5Y): 0
Trailing EPS: -0.23

Avenue Therapeutics stock forecasts for 2022-2027

DateOpen PriceClose PriceChange

Avenue Therapeutics Stock Forecast for 2022

March 2022 0 0 0%
April 2022 0 0 0%
May 2022 0 0 0%
June 2022 0 0 0%
July 2022 0 0 0%
August 2022 0 0 0%
September 2022 0 0 0%
October 2022 0 0 0%
November 2022 0 0 0%
December 2022 0 0 0%

Avenue Therapeutics Stock Forecast for 2023

January 2023 0 0 0%
March 2023 0 0 0%
March 2023 0 0 0%
April 2023 0 0 0%
May 2023 0 0 0%
June 2023 0 0 0%